The diagnostic tools are in place, but the connection between imaging machines and data management systems needs to be tighter if cardiovascular practices are going to keep up with the ever-growing patient volume, experts at Siemens Medical Solutions said from the American Heart Association's (AHA) Scientific Sessions.
CoreValve’s patented ReValving System, consisting of an 18-French delivery catheter, was used to percutaneously implant ...
ACC together with AHA and other key healthcare organizations, has launched "Door to Balloon (D2B): An Alliance for Quality." A Guidelines Applied in Practice (GAP) Program, the D2B campaign is aimed at improving the timeliness of lifesaving therapy for patients with heart attacks at the nation's hospitals that perform emergency angioplasty.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Toshiba America Medical Systems, Inc. held a grand opening Wednesday of the new Toshiba Education Center, a $6 million ...
Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...
Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...
The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.
Hospitals and other medical facilities across the state of Washington will receive $1 million in grant money allocated ...
November 12, 2006
